Healthcare

HealthCall Group Plc

Healthcall Group plc provides healthcare services. Their duty doctor service remains the core of their activities. Primary care facilities point the way towards significant new developments and opportunities. The company now operates 26 primary care centres throughout the United Kingdom which specialise in optical clinics, occupational therapy, physiotherapy and chiropody. The company acquired, Emergency Medical Services Ltd and Healthcall Optical Services Ltd.

Kemeta

Managing Metabolism in a Single Breath.  KemetaTMis commercializing  palm-sized breath analysis systems for monitoring the body’s metabolism with an initial focus on weight management and the prevention of weight-related diseases such as type 2 diabetes, cardiovascular disease, hypertension, stroke and cancers.

Kemeta’s patented breath sensing technology specifically detects and measures breath acetone, the only known, medically recognized breath biomarker for fat metabolism.

CureMark

Curemark is a socially driven biotechnology and development company whose focus is addressing the unmet health needs of individuals in the areas of neurology and gastrointestinal/pancreatic secretory deficiencies.

PharmaJet

PharmaJet delivers pharmaceuticals – vaccines and drugs – through the skin – without the pain of a needle – we are needle-free. We accomplish this using jet injection technology. We do not use needles – big or small, or patches of any kind.

Our needle-free delivery device is FDA cleared for marketing. It can deliver 0.5 ml of a liquid medication through the skin of the arm, the abdomen or the thigh, into the muscle (intramuscular or IM area) where many vaccines are routinely delivered, or into the subcutaneous layer or SC depth between the skin and muscle, where insulin is injected. In fact PharmaJet can be used to inject just about any licensed injectable liquid medicine like vaccines for flu, and drugs like generic sumatriptan and women’s reproductive hormones to treat infertility.

We have a pipeline of new products underway. A 0.1 ml device is under development for intradermal delivery into the 2 mm upper layer of the skin where the immune system is very active. Another product, providing a variable volume between 0.1 and 1.0 ml is underway for drug delivery.

Our mission to serve the global community is shared by employees and investors. We want fewer needle injections because it means a safer work place with less exposure to needle stick injuries, reduces the amount of hazardous sharps medical waste and provides better control over the spread of blood borne HIV and hepatitis from needle reuse.

We would like to help children avoid needle jabs when bravely taking their childhood vaccinations and booster shots. We also serve their pediatricians, and nurses who give the shots, and tens of millions of “belenophobics” who until now have had no practical recourse to their fear of needles.